Xolair 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FCMXZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,721
Award facts
- Contract value 100% obligated
- $3,720.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Xolair 300 mg/2 mL syringes. The contract is valued at $3,720.96 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. This award was made without a set-aside designation, allowing the vendor to compete on the open market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. Xolair (omalizumab) is a monoclonal antibody therapy typically used for allergic asthma and chronic urticaria treatment, representing the specialized pharmaceutical products that DMS Pharmaceutical Group routinely supplies to Department of Defense healthcare sites as a critical participant in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FCMXZ?
SPE2DB25FCMXZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FCMXZ worth?
The government has obligated $3,721 on SPE2DB25FCMXZ.
Is contract SPE2DB25FCMXZ an order under another contract?
Yes. SPE2DB25FCMXZ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMXZ competed?
The extent of competition for SPE2DB25FCMXZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award